Literature DB >> 23893276

The use of cannabinoids in chronic pain.

Timothy David Reynolds1, Hannah Louise Osborn.   

Abstract

We present the case of a 56-year-old man who developed chronic pain following the excision of a facial cancer that was poorly controlled despite multiple analgesic medications. Following the starting of nabilone (a synthetic cannabinoid) his pain control was greatly improved and this had a huge impact on his quality of life. We also managed to significantly reduce his doses of opioid analgesia and ketamine. We review the current literature regarding the medicinal use of cannabinoids, with an emphasis on chronic pain, in an attempt to clarify their role and how to select patients who may benefit from this treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23893276      PMCID: PMC3736518          DOI: 10.1136/bcr-2013-010417

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

Review 1.  Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.

Authors:  Mary E Lynch; Fiona Campbell
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

2.  [Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial].

Authors:  Martin Pinsger; Wolfgang Schimetta; Dieter Volc; Erich Hiermann; Franz Riederer; Werner Pölz
Journal:  Wien Klin Wochenschr       Date:  2006-06       Impact factor: 1.704

3.  Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.

Authors:  D I Abrams; C A Jay; S B Shade; H Vizoso; H Reda; S Press; M E Kelly; M C Rowbotham; K L Petersen
Journal:  Neurology       Date:  2007-02-13       Impact factor: 9.910

4.  Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.

Authors:  David M Berlach; Yoram Shir; Mark A Ware
Journal:  Pain Med       Date:  2006 Jan-Feb       Impact factor: 3.750

5.  Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.

Authors:  J Manzanares; Md Julian; A Carrascosa
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

6.  Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.

Authors:  B Frank; M G Serpell; J Hughes; J N S Matthews; D Kapur
Journal:  BMJ       Date:  2008-01-08
  6 in total
  1 in total

1.  Evaluation of Δ(9)-tetrahydrocannabinol metabolites and oxidative stress in type 2 diabetic rats.

Authors:  Zeynep Mine Coskun; Sema Bolkent
Journal:  Iran J Basic Med Sci       Date:  2016-02       Impact factor: 2.699

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.